Related Experiment Video
Updated: Aug 10, 2025
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Daniel Clayton-Chubb1,2, William Kemp1,2, Ammar Majeed1,2
1Department of Gastroenterology, The Alfred Hospital, Melbourne, VIC 3004, Australia.
Non-alcoholic fatty liver disease (NAFLD) is linked to liver and heart problems due to metabolic issues. This review covers NAFLD
Area of Science:
- Hepatology and Cardiology
- Metabolic Syndrome Research
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a widespread condition causing significant liver and cardiovascular morbidity and mortality.
- NAFLD is closely linked to insulin resistance and metabolic dysregulation, complicating treatment and risk stratification.
Purpose of the Study:
- To review the development, progression, and pathophysiology of NAFLD.
- To discuss tools for identifying high-risk patients for liver and cardiovascular complications.
- To outline current and emerging treatment strategies and future research directions for NAFLD.
Main Methods:
- Comprehensive literature review of NAFLD pathophysiology, risk stratification tools, and therapeutic options.
Main Results:
- NAFLD's complex pathophysiology presents challenges in developing effective pharmacological treatments.
- Accurate risk stratification is crucial for managing both liver and cardiovascular outcomes in NAFLD patients.
Conclusions:
- Effective management of NAFLD requires a multi-faceted approach addressing its metabolic underpinnings.
- Further research is needed to refine risk assessment tools and develop targeted therapies for NAFLD.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:28Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
01:26Atherosclerosis III: Management